The pathogenesis of B-cell non-Hodgkin lymphoma after exposure to C. burnetii: a micro-array study to unravel the genetic pathway

Withdrawn

• Conditions: lymphatic cancer; non-Hodgkin lymphoma; 10025320; 10004018

• Registration Number: NL-OMON46451
• Lead Sponsor: Jeroen Bosch Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 7

Inclusion Criteria

prior history of non-Hodgkin lymphoma; past exposure to C. burnetii, determined with serology; signed informed consent

Exclusion Criteria

< 18 years of age; legal incapability; current treatment with cytostatics for other malignancy (burden for patients too high)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome of this study is the fold-increase in gene-expression in a<br /><br>panel of preselected genes. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>